Kodiak Sciences Inc - ESG Rating & Company Profile powered by AI
If you work at Kodiak Sciences Inc and you wish to use your ESG rating, please get in touch. This webpage is a zero-cost E,S&G analysis covering Kodiak Sciences Inc. Browse to the end of this page for potential risks for Kodiak Sciences Inc based on industry, geography and marketcap.
Kodiak Sciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 6.7, social score of 4.6 and governance score of 4.0.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Kodiak Sciences Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kodiak Sciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Kodiak Sciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Kodiak Sciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Kodiak Sciences Inc offer flexible work?
Sign up for free to unlockDoes Kodiak Sciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kodiak Sciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kodiak Sciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose water use targets?
Sign up for free to unlockDoes Kodiak Sciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Kodiak Sciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Kodiak Sciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kodiak Sciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kodiak Sciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kodiak Sciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kodiak Sciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose its waste policy?
Sign up for free to unlockDoes Kodiak Sciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose energy use targets?
Sign up for free to unlockDoes Kodiak Sciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kodiak Sciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kodiak Sciences Inc
These potential risks are based on the size, segment and geographies of the company.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.